Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis, characterisation and in vitro pharmacological evaluation

MLA

Celine J. Marmion, et al. Ruthenium(III) Dimethyl Sulfoxide Pyridinehydroxamic Acid Complexes as Potential Antimetastatic Agents: Synthesis, Characterisation and in Vitro Pharmacological Evaluation. Jan. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c3e200956c191958774cc2ee0f166416&authtype=sso&custid=ns315887.

APA

Celine J. Marmion, Alberta Bergamo, Gianni Sava, Darren M. Griffith, Ennio Zangrando, & Sara Cecco. (2008). Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis, characterisation and in vitro pharmacological evaluation.

Chicago

Celine J. Marmion, Alberta Bergamo, Gianni Sava, Darren M. Griffith, Ennio Zangrando, and Sara Cecco. 2008. “Ruthenium(III) Dimethyl Sulfoxide Pyridinehydroxamic Acid Complexes as Potential Antimetastatic Agents: Synthesis, Characterisation and in Vitro Pharmacological Evaluation,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c3e200956c191958774cc2ee0f166416&authtype=sso&custid=ns315887.